GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » Other Long Term Assets

Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Other Long Term Assets : ¥26.3 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals Other Long Term Assets?

Chengdu Olymvax Biopharmaceuticals's other long-term assets for the quarter that ended in Mar. 2025 was ¥26.3 Mil.

Chengdu Olymvax Biopharmaceuticals's quarterly other long-term assets increased from Sep. 2024 (¥22.8 Mil) to Dec. 2024 (¥27.4 Mil) but then stayed the same from Dec. 2024 (¥27.4 Mil) to Mar. 2025 (¥26.3 Mil).

Chengdu Olymvax Biopharmaceuticals's annual other long-term assets increased from Dec. 2022 (¥25.6 Mil) to Dec. 2023 (¥52.6 Mil) but then declined from Dec. 2023 (¥52.6 Mil) to Dec. 2024 (¥27.4 Mil).


Chengdu Olymvax Biopharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Chengdu Olymvax Biopharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Olymvax Biopharmaceuticals Other Long Term Assets Chart

Chengdu Olymvax Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.35 39.63 25.62 52.63 27.37

Chengdu Olymvax Biopharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.56 28.21 22.81 27.37 26.29

Chengdu Olymvax Biopharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Chengdu Olymvax Biopharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
Executives
Wu Qiang Core technical personnel
Chen Dao Yuan Core technical personnel
Li Hong Guang Core technical personnel
Fan Shao Wen Directors, senior managers
Ma Heng Jun senior management
Wu Wei senior management
Fan Fan Director
Chen Ai Min Director
Tan Yong senior management
Lu Lu Director
Yu Yun Hui Director
Zhang Li Ying Core technical personnel
Chen Ke Ping Core technical personnel
Yang Feng Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines